Cancer type | Expression | Role | Biological functions | Related genes | Refs. |
---|---|---|---|---|---|
Breast cancer | Up | Oncogenic | Promotes cell proliferation, migration and invasion | miR-384/HDGF | |
miR-330-5p/PKM | |||||
miR-326/ITGA5, Vav2/Rac1 | |||||
Osteosarcoma | Up | Oncogenic | Promotes cell proliferation, migration, invasion and EMT | miR-151a-3p/RAB22A, miR-196a-5p/HOXC8 | |
Glioma | Up | Oncogenic | Promores cell proliferation, inhibits apoptosis, and regulates cell cycle | KLF2, p21, EZH2 | [24] |
Laryngeal cancer | UP | Oncogenic | Promotes cell migration, invasion and cell viability, glycolysis | miR-384/WEE1, MMP2, MMP9 | |
miR-340-5p/YAP1, Wnt/β-catenin | |||||
Gastric cancer | Up | Oncogenic | Promotes cell proliferation, migration, invasion and cell viability | EZH2, MED18 | [23] |
Colorectal cancer | Up | Oncogenic | Promotes cell proliferation, migration, invasion and cell viability | miR-182-5p/c-Myc, miR-539/RUNX2 | |
Renal cell carcinoma | Up | Oncogenic | Promotes cell proliferation, cell viability, migration, invasion and EMT and inhibits cell apoptosis | miR-139-5p/TOP2A, CDK6, Bax, Bcl-2, N-cadherin, E-cadherin, Vimentin | [57] |
Hepatocellular carcinomac | Up | Oncogenic | Promotes cell proliferation, apoptosis, migration, invasion, EMT and sorafenib resistance | miR-139-5p/BMI1, miR-326/SMAD3/ZEB1, miR-128/CD151/AKT/PI3K, N-cadherin, E-cadherin, Vimentin, Snail | |
Lung cancer | Up | Oncogenic | Promotes cell proliferation, migration and EMT, inhibits cell apoptosis and regulates cell cycle | TGF-β, IL-6/JAK2/STAT3 | |
Acute myeloid leukemia | Up | Oncogenic | Promotes cell proliferation and inhibits cell apoptosis | miR-758-3p/SRGN | |
Epithelial ovarian cancer | Up | Oncogenic | Promotes cell proliferation, invasion and glycolysis | CyclinD1, CDK1, MMP9, MMP3, GSK3β/β-catenin, EIF4A3-mRNA | |
Papillary thyroid carcinoma | Up | Oncogenic | Promotes cell proliferation, migration and invasion | miR-214-3p/PSMD10 | [76] |
Down | Tumor Suppressive | Promotes cell proliferation, migration and invasion | AKT/mTOR/ERK | [77] | |
Prostate cancer | UP | Oncogenic | Promotes cell proliferation, migration, invasion, EMT process and inhibits cell apoptosis | miR-577/SMURF1 | [78] |
Bladder cancer | Up | Oncogenic | Promotes cell proliferation, migration, invasion and EMT | miR-515-5p/GINS2 | [79] |
Oral squamous cell carcinoma | Up | Oncogenic | Promotes cell migration, invasion and proliferation | ELAVL1/NFYC, Wnt/β-catenin | [80] |